Latest News
Professional Cancer Associations Collaborate to Improve Treatment of Anemia in Adult Patients with Myelodysplastic Syndromes
The initiative will provide support and guidance to community hematologists/oncologists on the risk-stratification of MDS, selection of evidence-based and novel therapies for the management of anemia in patients with lower-risk MDS, and on best practices
Explore more from HOPA
Oncology Experts Join Together to Provide Best Possible Care for Adolescents and Young Adults with Cancer
The Hematology/Oncology Pharmacy Association (HOPA) has partnered with Stupid Cancer, the leader in young adult cancer advocacy, research, and support, to develop tools for healthcare providers who serve the adolescent and young adult (AYA) patient commun
The Role of the Pharmacist after Dobbs v. Jackson Women’s Health Organization Ruling
The Hematology/Oncology Pharmacy Association (HOPA) is committed to optimizing cancer care for all individuals. The recent U.S. Supreme Court decision, which overturned Roe v. Wade, imposes a significant barrier to the oncology community’s ability to ens
HOPA President Brings Expertise and Unique Perspective to Hematology/Oncology Pharmacy Practice
Heidi D. Finnes, PharmD, BCOP, FHOPA became President of the Hematology/ Oncology Pharmacy Association (HOPA) on April 1, 2022 at the association’s annual conference in Boston, Massachusetts.
Tracelyn Freeman Recipient of HOPA’s Top 10 Trainee Research Award
Tracelyn Freeman, PharmD, PGY2, was presented with HOPA’s Top 10 Trainee Research Award on April 25th for her research poster Hypomethylating Agents with or without Venetoclax in Adult Patients with Acute Myeloid Leukemia. Tracelyn is a Hematology/Oncol